Novel Use of the Proteasome Inhibitor Carfilzomib for Antibody Mediated Rejection After Lung Transplantation
Latest Information Update: 22 Dec 2015
At a glance
- Drugs Carfilzomib (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 22 Dec 2015 New trial record